Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRemuzgo-Martínez, Sara
dc.contributor.authorAtienza-Mateo, Belén
dc.contributor.authorOcejo‑Vinyals, J. Gonzalo
dc.contributor.authorGenre, Fernanda
dc.contributor.authorPulito-Cueto, Verónica
dc.contributor.authorMora Cuesta, Víctor Manuel
dc.contributor.authorTrallero Araguas, Ernesto
dc.contributor.authorSelva O'Callaghan, Albert
dc.date.accessioned2022-05-31T09:00:28Z
dc.date.available2022-05-31T09:00:28Z
dc.date.issued2021-11-19
dc.identifier.citationRemuzgo-Martínez S, Atienza-Mateo B, Ocejo-Vinyals JG, Genre F, Pulito-Cueto V, Mora-Cuesta VM, et al. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome. Sci Rep. 2021 Nov 19;11:22574.
dc.identifier.issn2045-2322
dc.identifier.urihttps://hdl.handle.net/11351/7603
dc.descriptionBiomarcadors; Miopaties inflamatòries idiopàtiques
dc.description.sponsorshipStudy partially supported by a grant from Spanish Society of Pulmonology and Thoracic Surgery (SEPAR 474-2017) and from Euronanomed III / Instituto de Salud Carlos III (ISCIII) (AC17/00027) awarded to SC. SR-M is supported by funds of the RETICS Program (RD16/0012/0009) from the ISCIII, co-funded by the European Regional Development Fund. BA-M is recipient of a ‘López Albo’ Post-Residency Programme funded by Servicio Cántabro de Salud. VP-C is supported by a pre-doctoral grant from IDIVAL (PREVAL 18/01). LL-G is supported by funds from IDIVAL (INNVAL 20/06). RP-F is supported by funds of START project (FOREUM18/34). DP-P is a recipient of a Río Hortega programme fellowship from the ISCIII, co-funded by the European Social Fund (ESF, ‘Investing in your future’) (CM20/00006). OG is staff personnel of Xunta de Galicia (Servizo Galego de Saude (SERGAS)) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and the European Union FEDER fund (RD16/0012/0014 (RIER) and PI17/00409). He is beneficiary of project funds from the Research Executive Agency (REA) of the European Union in the framework of MSCA-RISE Action of the H2020 Programme, Project 734899—Olive-Net. RL-M is a recipient of a Miguel Servet type I programme fellowship from the ISCIII, co-funded by the ESF (CP16/00033).
dc.language.isoeng
dc.publisherNature Research
dc.relation.ispartofseriesScientific reports;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPolimorfisme genètic
dc.subjectPulmons - Malalties - Aspectes genètics
dc.subjectMalalties autoimmunitàries - Aspectes genètics
dc.subject.meshLung Diseases, Interstitial
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshDiagnosis, Differential
dc.titleRole of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41598-021-01992-y
dc.subject.decsenfermedades pulmonares intersticiales
dc.subject.decspolimorfismo de nucleótido único
dc.subject.decsdiagnóstico diferencial
dc.relation.publishversionhttps://doi.org/10.1038/s41598-021-01992-y
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Remuzgo-Martínez S, Genre F, Pulito-Cueto V] Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Diseases of the Musculoskeletal System, IDIVAL, 39011 Santander, Spain. [Atienza-Mateo B] Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Diseases of the Musculoskeletal System, IDIVAL, 39011 Santander, Spain. López Albo’ Post Residency Programme, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Ocejo-Vinyals JG] Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Mora-Cuesta VM] Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Diseases of the Musculoskeletal System, IDIVAL, 39011 Santander, Spain. Pneumology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Trallero-Araguas E] Unitat de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Selva-O'Callaghan A] Unitat de Malalties Autoimmunes Sistèmiques, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid34799647
dc.identifier.wos000720679400011
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple